|
(P1732) |
Long term clinical results of bioresorbable Absorb scaffolds using
the PSP-technique |
| |
|
S. Markovic, C. Kugler, S. Dragomir, W. Rottbauer, J. Wöhrle (Ulm) |
|
(P1733) |
Incidence and Characteristics of In-Stent and In-Scaffold Fractures: a Novel Optical Coherence Tomography Pattern-Based Classification |
| |
|
K. Schochlow, F. Blachutzik, N. F. Boeder, L. Lorenz, M. Weissner, S. Achenbach, H. Nef, T. Gori (Mainz, Erlangen, Gießen) |
|
(P1734) |
Clinical Outcomes 3 Years after Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes |
| |
|
F. Wendling, M. Weissner, S. Gönner, M. Knorr, P. Wenzel, R. S. von Bardeleben, F. P. Schmidt, T. Münzel, T. Gori (Mainz) |
|
(P1735) |
Microgel-functionalization of polylactide improves mechanical properties and stabilizes tissue pH during degradation of biodegradable stents |
| |
|
M. Almalla, K. Fehér, T. Romstadt, A. Molano Lopez, A. Pich, L. Bürgermeister, S. Jockenhövel, A. Cornelissen, N. Schaaps, J. Schröder, N. Marx, F. Vogt (Aachen) |
|
(P1736) |
Clinical, Angiographic, Functional and Imaging Presentation of in-Scaffold Restenosis after Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds |
| |
|
M. Weissner, P. Wenzel, F. P. Schmidt, K. Schochlow, L. Lorenz, C. Rolfes, T. Münzel, T. Gori (Mainz) |
|
(P1737) |
Preclinical evaluation of degradation processes in novel bioresorbable magnesium scaffolds |
| |
|
T. Koppara, P. Zumstein, C. Harder, P. Ruppelt, T. Ibrahim, K.-L. Laugwitz, H. Schunkert, A. Kastrati, M. Joner (München, Berlin) |